FOXO1 and squamous cell carcinoma: The results showed that the high FOXO1 expression levels significantly elevated the survival probability among head and Neck squamous cell carcinoma patients (n = 255) (HR, 0.61 (0.38–0.98), log-rank P = 0.041), reducing the death risk up to 39% over three year period (Fig. 5A).